Evidence map›Paper›PMID 19400724›Full record

ReviewAnnual review of neuroscience2009

Neuropathic pain: a maladaptive response of the nervous system to damage.

Michael Costigan, Joachim Scholz, Clifford J Woolf

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Annual review of neuroscience, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 940 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
940citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04798573 active not recruitingnot on this mapstarted 2012, after this paper: background citation

Phenomics and Genomics of Clinically Relevant Chronic Postsurgical Pain: A Multicenter Prospective Study

TypeobservationalSponsorUniversity Health Network, TorontoRan2012 to 2025Enrolled10,000ConditionsChronic Pain, Surgery
NCT04920097 nacompletednot on this mapstarted 2021, after this paper: background citation

Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy

TypeinterventionalSponsorThe University of Texas Health Science Center, HoustonRan2021 to 2026Enrolled238ConditionsChemotherapy-induced NeuropathyArmsIn-person training for seed placement and APA, Virtual training for seed placement and APA, Usual Care, Post-training zoom session for seed placement and APA coaching
3 · Its place in the literature

Who cites it

940 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Glial cells in neuropathic pain.Physiological reviews · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Semaphorins and Their Role in Neuropathic Pain.Life (Basel, Switzerland) · 2026
    Review
  18. Review
  19. Article
  20. Article

880 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael CostiganNeural Plasticity Research Group, Department of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA. mcostigan@partners.org
Joachim Scholz
Clifford J Woolf

Funding

Transsynaptic Neurodegeneration after Nerve InjuryR01NS050408 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI SCHOLZ, JOACHIM · 2007 to 2010
$1.2M
NINDS NIH HHS R01 NS050408
6 · The paper itself

Abstract

Neuropathic pain is triggered by lesions to the somatosensory nervous system that alter its structure and function so that pain occurs spontaneously and responses to noxious and innocuous stimuli are pathologically amplified. The pain is an expression of maladaptive plasticity within the nociceptive system, a series of changes that constitute a neural disease state. Multiple alterations distributed widely across the nervous system contribute to complex pain phenotypes. These alterations include ectopic generation of action potentials, facilitation and disinhibition of synaptic transmission, loss of synaptic connectivity and formation of new synaptic circuits, and neuroimmune interactions. Although neural lesions are necessary, they are not sufficient to generate neuropathic pain; genetic polymorphisms, gender, and age all influence the risk of developing persistent pain. Treatment needs to move from merely suppressing symptoms to a disease-modifying strategy aimed at both preventing maladaptive plasticity and reducing intrinsic risk.

Indexed as

Adaptation, PhysiologicalAfferent PathwaysAnimalsHumansNervous SystemNeuralgiaNeuronal PlasticityNociceptorsPain ThresholdPeripheral Nervous System DiseasesSensory Receptor CellsSignal TransductionSpinal Nerve Roots

Identifiers

PMID19400724
PMCPMC2768555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.